Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets-Reference-Cited by-同舟云学术

Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets

Published:2020-03-16 Issue:2 Volume:72 Page:412-429
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hwang Seonghwan¹,He Yong¹,Xiang Xiaogang¹,Seo Wonhyo¹,Kim Seung‐Jin¹,Ma Jing¹,Ren Tianyi¹^ORCID,Park Seol Hee¹,Zhou Zhou¹,Feng Dechun¹,Kunos George²,Gao Bin¹

Affiliation:

1. Laboratory of Liver Diseases National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda MD

2. Laboratory of Physiologic Studies National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda MD

Funder

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31031

Reference37 articles.

1. Mechanisms of NAFLD development and therapeutic strategies

2. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation

3. Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?

4. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

5. Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1;Metabolism;2024-10

2. Review of the potential value of serum interleukin levels as prognostic biomarkers of liver failure;World Journal of Clinical Cases;2024-09-26

3. Discovery of N-Aryl-N′-[4-(aryloxy)cyclohexyl]squaramide-Based Inhibitors of LXR/SREBP-1c Signaling Pathway Ameliorating Steatotic Liver Disease: Navigating the Role of SIRT6 Activation;Journal of Medicinal Chemistry;2024-09-11

4. Role of Neutrophils in the Development of Steatotic Liver Disease;Seminars in Liver Disease;2024-08-08

5. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease;Frontiers in Immunology;2024-08-02